Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions
Year: 2017
Type: article
Abstract: Background: To evaluate the efficacy of a run-to-run (R2R) adaptive wearable artificial pancreas (AP) after 1 month of closed-loop glucose control in subjects with type 1 diabetes (T1D) under free-living conditions. Methods: Eighteen adults, who had previously completed a 1-month closed-loop study with a non-adaptive artificial pancreas (NA-AP), volunteered for an additional 1-month extension study in which the AP was equipped with an adaptive model predictive control algorithm (R2R-AP). Continuous glucose monitoring data were analyzed on an intention-to-treat basis by comparing the last week of R2R-AP versus the last week of NA-AP. The primary endpoint was the time in target range (3.9–10 mmol/L) over 24 h. Results: Time in target with R2R-AP is higher than with the NA-AP, although the increase was not significant: mean 66.90% (standard deviation: 13.34) versus 61.82% (11.12), P = 0.10. The increase was significant during the night: 74.01% (14.61) versus 64.31% (15.71), P = 0.03, and at wake-up time: median 92.43% (25th; 75th percentiles: 78.22; 99.53) versus 84.54% (57.14; 88.52), P = 0.02. Time above target (>10 mmol/L) during the whole day was 30.98% (13.22) versus 36.17% (11.53), P = 0.10. The decrease was significant during the night: 24.23% (15.03) versus 34.49% (16.25), P = 0.03, and at wake-up time: 7.57% (0.00; 14.29) versus 14.29% (8.25; 42.86), P = 0.05. Time spent below target (<3.9 mmol/L) was low and similar to the two treatments. Conclusions: R2R-AP improves glucose control over NA-AP in subjects with T1D during the night, and it maintains equivalent control performance during the day in a 1-month trial under free-living conditions.
Authors: Mirko Messori, Jort Kropff, Simone Del Favero, Jerome Place, Roberto Visentin, Roberta Calore, Chiara Toffanin, Federico Di Palma, Giordano Lanzola, Anne Farret, Federico Boscari, Silvia Galasso, Angelo Avogaro, Patrick Keith-Hynes, Boris P. Kovatchev, Daniela Bruttomesso, Lalo Magni, J. Hans DeVries, Eric Renard, Claudio Cobelli
Institutions: University of Pavia, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, University of Padua, Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Institut de Génomique Fonctionnelle, University of Virginia
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2749766521
